메뉴 건너뛰기




Volumn 43, Issue 9, 2011, Pages 676-681

Herbal hepatotoxicity by kava: Update on pipermethystine, flavokavain B, and mould hepatotoxins as primarily assumed culprits

Author keywords

Drug induced liver injury; Herbal hepatotoxicity; Herbs induced liver injury; Kava; Kava hepatotoxicity; Piper methysticum

Indexed keywords

AFLATOXIN; DEMETHOXYYANGONIN; DESOGESTREL; DIHYDROKAWAIN; DIHYDROMETHYSTICIN; ETHINYLESTRADIOL; FLAVOKAVAIN B; HYPERICUM PERFORATUM EXTRACT; KAVA; KAVA EXTRACT; KAVALACTONE; KAWAIN; LACTONE DERIVATIVE; METHYSTICIN; MOULD HEPATOTOXIN; PARACETAMOL; PAROXETINE; PIPERMETHYSTINE; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; YANGONIN;

EID: 79961127236     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.01.018     Document Type: Review
Times cited : (66)

References (61)
  • 1
    • 0038664368 scopus 로고    scopus 로고
    • Kava: herbal panacea or liver poison?
    • Moulds R.F.W., Malani J. Kava: herbal panacea or liver poison?. Med J Aust 2003, 178:451-453.
    • (2003) Med J Aust , vol.178 , pp. 451-453
    • Moulds, R.F.W.1    Malani, J.2
  • 2
    • 0038399798 scopus 로고    scopus 로고
    • Kava hepatotoxicity with Western herbal products: does it occur with traditional kava use?
    • Currie B.J., Clough A.R. Kava hepatotoxicity with Western herbal products: does it occur with traditional kava use?. Med J Aust 2003, 178:421-422.
    • (2003) Med J Aust , vol.178 , pp. 421-422
    • Currie, B.J.1    Clough, A.R.2
  • 4
    • 0037532579 scopus 로고    scopus 로고
    • Kava extracts: safety and risks including rare hepatotoxicity
    • Teschke R., Gaus W., Loew D. Kava extracts: safety and risks including rare hepatotoxicity. Phytomedicine 2003, 10:440-446.
    • (2003) Phytomedicine , vol.10 , pp. 440-446
    • Teschke, R.1    Gaus, W.2    Loew, D.3
  • 5
    • 0038249051 scopus 로고    scopus 로고
    • Toxicity of kava pyrones, drug safety and precautions - a case study
    • Schulze J., Raasch W., Siegers C.P. Toxicity of kava pyrones, drug safety and precautions - a case study. Phytomedicine 2003, 10(Suppl IV):68-73.
    • (2003) Phytomedicine , vol.10 , Issue.SUPPL. IV , pp. 68-73
    • Schulze, J.1    Raasch, W.2    Siegers, C.P.3
  • 6
    • 38849140694 scopus 로고    scopus 로고
    • Kava: a risk-benefit assessment
    • Elsevier Churchill Livingstone, St. Louis (Missouri), M. Mills, K. Bone (Eds.)
    • Schmidt M., Morgan M., Bone K., McMillan J. Kava: a risk-benefit assessment. The essential guide to herbal safety 2005, 155-221. Elsevier Churchill Livingstone, St. Louis (Missouri). M. Mills, K. Bone (Eds.).
    • (2005) The essential guide to herbal safety , pp. 155-221
    • Schmidt, M.1    Morgan, M.2    Bone, K.3    McMillan, J.4
  • 7
    • 78751566523 scopus 로고    scopus 로고
    • Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate?
    • Teschke R., Wolff A. Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate?. Reg Toxicol Pharmacol 2010, 10.1016/j.yrtph.2010.09.006.
    • (2010) Reg Toxicol Pharmacol
    • Teschke, R.1    Wolff, A.2
  • 8
    • 56349138698 scopus 로고    scopus 로고
    • Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases
    • Teschke R., Schwarzenboeck A., Hennermann K.H. Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases. Eur J Gastroenterol Hepatol 2008, 20:1182-1193.
    • (2008) Eur J Gastroenterol Hepatol , vol.20 , pp. 1182-1193
    • Teschke, R.1    Schwarzenboeck, A.2    Hennermann, K.H.3
  • 9
    • 70350766713 scopus 로고    scopus 로고
    • Kava hepatotoxicity: regulatory data selection and causality assessment
    • Teschke R., Wolff A. Kava hepatotoxicity: regulatory data selection and causality assessment. Dig Liver Dis 2009, 41:891-901.
    • (2009) Dig Liver Dis , vol.41 , pp. 891-901
    • Teschke, R.1    Wolff, A.2
  • 10
    • 77956692082 scopus 로고    scopus 로고
    • Kava hepatotoxicity: comparative study of two structured quantitative methods for causality assessment
    • Teschke R., Fuchs J., Bahre R., Genthner A., Wolff A. Kava hepatotoxicity: comparative study of two structured quantitative methods for causality assessment. J Clin Pharm Ther 2010, 35:545-563.
    • (2010) J Clin Pharm Ther , vol.35 , pp. 545-563
    • Teschke, R.1    Fuchs, J.2    Bahre, R.3    Genthner, A.4    Wolff, A.5
  • 11
    • 78349260262 scopus 로고    scopus 로고
    • Kava hepatotoxicity - a clinical review
    • Teschke R. Kava hepatotoxicity - a clinical review. Ann Hepatol 2010, 9:251-265.
    • (2010) Ann Hepatol , vol.9 , pp. 251-265
    • Teschke, R.1
  • 12
    • 38849103386 scopus 로고    scopus 로고
    • The quality of kava consumed in the South Pacific
    • Lebot V. The quality of kava consumed in the South Pacific. HerbalGram 2006, 71:34-37.
    • (2006) HerbalGram , vol.71 , pp. 34-37
    • Lebot, V.1
  • 13
    • 38849087754 scopus 로고    scopus 로고
    • Quality criteria for kava
    • Schmidt M. Quality criteria for kava. HerbalGram 2007, 73:45-49.
    • (2007) HerbalGram , vol.73 , pp. 45-49
    • Schmidt, M.1
  • 14
    • 78349273977 scopus 로고    scopus 로고
    • Kava hepatotoxicity: pathogenetic aspects and prospective considerations
    • Teschke R. Kava hepatotoxicity: pathogenetic aspects and prospective considerations. Liver Int 2010, 30:1270-1279.
    • (2010) Liver Int , vol.30 , pp. 1270-1279
    • Teschke, R.1
  • 15
    • 78650637966 scopus 로고    scopus 로고
    • Kava: a comprehensive review of efficacy, safety, and psychopharmacology
    • Sarris J., LaPorte E., Schweitzer I. Kava: a comprehensive review of efficacy, safety, and psychopharmacology. Aust N Z J Psychiatry 2011, 45:36-44.
    • (2011) Aust N Z J Psychiatry , vol.45 , pp. 36-44
    • Sarris, J.1    LaPorte, E.2    Schweitzer, I.3
  • 16
    • 0004039221 scopus 로고    scopus 로고
    • Lippincott Williams & Wilkins, Philadelphia
    • Zimmerman H.J. Hepatotoxicity 1999, Lippincott Williams & Wilkins, Philadelphia.
    • (1999) Hepatotoxicity
    • Zimmerman, H.J.1
  • 17
    • 68149157299 scopus 로고    scopus 로고
    • Drug-induced liver injury: what was new in 2008?
    • Liss G., Lewis J.H. Drug-induced liver injury: what was new in 2008?. Exp Opin Drug Metab Toxicol 2009, 5:843-860.
    • (2009) Exp Opin Drug Metab Toxicol , vol.5 , pp. 843-860
    • Liss, G.1    Lewis, J.H.2
  • 18
    • 77952702755 scopus 로고    scopus 로고
    • Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method
    • Rockey D.C., Seeff L.B., Rochon J., et al. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology 2010, 51:2117-2126.
    • (2010) Hepatology , vol.51 , pp. 2117-2126
    • Rockey, D.C.1    Seeff, L.B.2    Rochon, J.3
  • 19
    • 34548643763 scopus 로고    scopus 로고
    • The safety of kava - a regulatory perspective
    • Richardson W.N., Henderson L. The safety of kava - a regulatory perspective. Br J Clin Pharmcol 2007, 64:418-420.
    • (2007) Br J Clin Pharmcol , vol.64 , pp. 418-420
    • Richardson, W.N.1    Henderson, L.2
  • 20
    • 77949366119 scopus 로고    scopus 로고
    • Severe hepatotoxicity by Indian Ayurvedic herbal products: a structured causality assessment
    • Teschke R., Bahre R. Severe hepatotoxicity by Indian Ayurvedic herbal products: a structured causality assessment. Ann Hepatol 2009, 8:258-266.
    • (2009) Ann Hepatol , vol.8 , pp. 258-266
    • Teschke, R.1    Bahre, R.2
  • 21
    • 70449133964 scopus 로고    scopus 로고
    • Herbal and dietary supplement hepatotoxicity
    • Navarro V.J. Herbal and dietary supplement hepatotoxicity. Semin Liver Dis 2009, 29:373-382.
    • (2009) Semin Liver Dis , vol.29 , pp. 373-382
    • Navarro, V.J.1
  • 22
    • 55249125241 scopus 로고    scopus 로고
    • Kava hepatotoxicity: a European view
    • Available at: [accessed 03.09.10].
    • Teschke, R, Schwarzenboeck A, Akinci A. Kava hepatotoxicity: a European view. New Zeal Med J 2008;121:1283. Available at: [accessed 03.09.10]. http://www.nzma.org.nz/journal/121-1283/3296/.
    • (2008) New Zeal Med J , vol.121 , pp. 1283
    • Teschke, R.1    Schwarzenboeck, A.2    Akinci, A.3
  • 23
    • 79961127578 scopus 로고    scopus 로고
    • WHO (World Health Organization). Assessments of the risk of hepatotoxicity with kava products. WHO Document Production Services: Geneva, Switzerland.
    • WHO (World Health Organization). Assessments of the risk of hepatotoxicity with kava products. WHO Document Production Services: Geneva, Switzerland; 2007.
    • (2007)
  • 24
    • 40549094283 scopus 로고    scopus 로고
    • Efficacy of extracting solvents to chemical compounds of kava (Piper methysticum) root
    • Xuan T.D., Fukuta A.A., Wie A.C., Elzaawely A.A., Khanh T.D., Tawata S. Efficacy of extracting solvents to chemical compounds of kava (Piper methysticum) root. J Nat Med 2008, 62:188-194.
    • (2008) J Nat Med , vol.62 , pp. 188-194
    • Xuan, T.D.1    Fukuta, A.A.2    Wie, A.C.3    Elzaawely, A.A.4    Khanh, T.D.5    Tawata, S.6
  • 25
    • 84888458121 scopus 로고    scopus 로고
    • Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical, and clinical studies based on a review of the evidence
    • in press.
    • Teschke R, Qiu SX, Xuan TD, Lebot V. Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical, and clinical studies based on a review of the evidence. Phytother Res; in press.
    • Phytother Res
    • Teschke, R.1    Qiu, S.X.2    Xuan, T.D.3    Lebot, V.4
  • 26
    • 56549100205 scopus 로고    scopus 로고
    • Causality assessment in hepatotoxicity by drugs and dietary supplements
    • Teschke R., Schwarzenboeck A., Hennermann K.H. Causality assessment in hepatotoxicity by drugs and dietary supplements. Br J Clin Pharmacol 2008, 66:758-766.
    • (2008) Br J Clin Pharmacol , vol.66 , pp. 758-766
    • Teschke, R.1    Schwarzenboeck, A.2    Hennermann, K.H.3
  • 27
    • 0032553342 scopus 로고    scopus 로고
    • Necrotising hepatitis after taking herbal remedies
    • [Article in German]
    • Strahl S., Ehret V., Dahm H.H., Maier K.P. Necrotising hepatitis after taking herbal remedies. Dtsch Med Wschr 1998, 123:1410-1414. [Article in German].
    • (1998) Dtsch Med Wschr , vol.123 , pp. 1410-1414
    • Strahl, S.1    Ehret, V.2    Dahm, H.H.3    Maier, K.P.4
  • 28
    • 34247135372 scopus 로고    scopus 로고
    • Kava feeding in rats does not cause liver injury nor enhance galactosamine-induced hepatitis
    • DiSilvestro R.A., Zhang W., DiSilvestro D.J. Kava feeding in rats does not cause liver injury nor enhance galactosamine-induced hepatitis. Food Chem Toxicol 2007, 45:1293-1300.
    • (2007) Food Chem Toxicol , vol.45 , pp. 1293-1300
    • DiSilvestro, R.A.1    Zhang, W.2    DiSilvestro, D.J.3
  • 29
    • 78349253039 scopus 로고    scopus 로고
    • Risk of kava hepatotoxicity and the FDA consumer advisory
    • Teschke R., Schulze J. Risk of kava hepatotoxicity and the FDA consumer advisory. J Am Med Assoc 2010, 304:2174-2175.
    • (2010) J Am Med Assoc , vol.304 , pp. 2174-2175
    • Teschke, R.1    Schulze, J.2
  • 30
    • 79251649167 scopus 로고    scopus 로고
    • Kava, the anxiolytic herb: back to basics to prevent liver injury?
    • Teschke R., Sarris J., Glass X., Schulze J. Kava, the anxiolytic herb: back to basics to prevent liver injury?. Br J Clin Pharmacol 2010, 10.1111/j.1365-2125.2010.03775.x.
    • (2010) Br J Clin Pharmacol
    • Teschke, R.1    Sarris, J.2    Glass, X.3    Schulze, J.4
  • 31
    • 78651302770 scopus 로고    scopus 로고
    • Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
    • 1.
    • Sarris J, Teschke R, Stough C, Scholey A, Schweitzer I. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward? Planta Med 2010;1. http://dx.doi.org/10.1055/s-0030-1250290.
    • (2010) Planta Med
    • Sarris, J.1    Teschke, R.2    Stough, C.3    Scholey, A.4    Schweitzer, I.5
  • 32
    • 78651346028 scopus 로고    scopus 로고
    • Kava hepatotoxicity solution: a six-point plan for new kava standardization
    • Teschke R., Sarris J., Lebot V. Kava hepatotoxicity solution: a six-point plan for new kava standardization. Phytomedicine 2011, 18:96-103.
    • (2011) Phytomedicine , vol.18 , pp. 96-103
    • Teschke, R.1    Sarris, J.2    Lebot, V.3
  • 33
    • 67349168679 scopus 로고    scopus 로고
    • Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures
    • Teschke R., Genthner A., Wolff A. Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures. J Ethnopharmacol 2009, 123:378-384.
    • (2009) J Ethnopharmacol , vol.123 , pp. 378-384
    • Teschke, R.1    Genthner, A.2    Wolff, A.3
  • 34
    • 0037989908 scopus 로고    scopus 로고
    • Piperidine alkaloids from Piper methysticum
    • Dragull K., Yoshida W.Y., Tang C.S. Piperidine alkaloids from Piper methysticum. Phytochem 2003, 63:193-198.
    • (2003) Phytochem , vol.63 , pp. 193-198
    • Dragull, K.1    Yoshida, W.Y.2    Tang, C.S.3
  • 35
    • 0026728263 scopus 로고
    • Kava: an overview
    • Singh Y.H. Kava: an overview. J Ethnopharmacol 1992, 37:13-45.
    • (1992) J Ethnopharmacol , vol.37 , pp. 13-45
    • Singh, Y.H.1
  • 37
    • 84888461618 scopus 로고    scopus 로고
    • Pipermethystine, an alkaloid from kava stem peelings, induces liver cell death via GSH depletion and modulation of MAPK and NF-κB signaling pathways
    • in press.
    • Qiu SX, Dagull K, Liu JH, et al. Pipermethystine, an alkaloid from kava stem peelings, induces liver cell death via GSH depletion and modulation of MAPK and NF-κB signaling pathways. Chem Res Toxicol; in press.
    • Chem Res Toxicol
    • Qiu, S.X.1    Dagull, K.2    Liu, J.H.3
  • 38
    • 84888453025 scopus 로고    scopus 로고
    • SPC Report. Pacific kava: a producer's guide. Secretariat of the Pacific Community; 2001. Suva, Fiji Islands. ISBN 982-203r-r810-0.
    • SPC Report. Pacific kava: a producer's guide. Secretariat of the Pacific Community; 2001. Suva, Fiji Islands. ISBN 982-203r-r810-0.
  • 39
    • 38849086101 scopus 로고    scopus 로고
    • Is the alkaloid pipermethystine connected with the claimed liver toxicity of kava products?
    • Lechtenberg M., Quandt B., Schmidt M., Nahrstedt A. Is the alkaloid pipermethystine connected with the claimed liver toxicity of kava products?. Pharmazie 2008, 63:71-74.
    • (2008) Pharmazie , vol.63 , pp. 71-74
    • Lechtenberg, M.1    Quandt, B.2    Schmidt, M.3    Nahrstedt, A.4
  • 40
    • 2442710270 scopus 로고    scopus 로고
    • In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones
    • Nerurkar P.V., Dragull K., Tang C.S. In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones. Toxicol Sci 2004, 79:106-111.
    • (2004) Toxicol Sci , vol.79 , pp. 106-111
    • Nerurkar, P.V.1    Dragull, K.2    Tang, C.S.3
  • 41
    • 34548636945 scopus 로고    scopus 로고
    • A re-evaluation of kava (Piper methysticum)
    • Ernst E. A re-evaluation of kava (Piper methysticum). Br J Clin Pharmacol 2007, 64:415-417.
    • (2007) Br J Clin Pharmacol , vol.64 , pp. 415-417
    • Ernst, E.1
  • 42
    • 34347232391 scopus 로고    scopus 로고
    • Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats
    • Lim S.T., Dragull K., Tang C.S., Bittenbender H.C., Efird J.T., Nerurkar P.V. Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats. Toxicol Sci 2007, 97:214-221.
    • (2007) Toxicol Sci , vol.97 , pp. 214-221
    • Lim, S.T.1    Dragull, K.2    Tang, C.S.3    Bittenbender, H.C.4    Efird, J.T.5    Nerurkar, P.V.6
  • 43
    • 33646500546 scopus 로고    scopus 로고
    • In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum)
    • Jhoo J.W., Freeman J.P., Heinze T.M., et al. In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum). J Agric Food Chem 2006, 54:3157-3162.
    • (2006) J Agric Food Chem , vol.54 , pp. 3157-3162
    • Jhoo, J.W.1    Freeman, J.P.2    Heinze, T.M.3
  • 44
    • 78349302551 scopus 로고    scopus 로고
    • The hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress trough modulation of IKK/NF-κB and MAPK signaling pathways
    • Zhou P., Gross S., Liu J.H., et al. the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress trough modulation of IKK/NF-κB and MAPK signaling pathways. FASEB J 2010, 24:4722-4732.
    • (2010) FASEB J , vol.24 , pp. 4722-4732
    • Zhou, P.1    Gross, S.2    Liu, J.H.3
  • 45
    • 0036183953 scopus 로고    scopus 로고
    • Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava kava) roots
    • Wu D., Yu L., Nair M.G., DeWitt D.L., Ramsewak R.S. Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava kava) roots. Phytomedicine 2002, 9:41-47.
    • (2002) Phytomedicine , vol.9 , pp. 41-47
    • Wu, D.1    Yu, L.2    Nair, M.G.3    DeWitt, D.L.4    Ramsewak, R.S.5
  • 46
    • 84888460842 scopus 로고    scopus 로고
    • Vanuatu Legislation: kava Act 2002. Available at: [accessed 30.11.10].
    • Vanuatu Legislation: kava Act 2002. Available at: [accessed 30.11.10]. http://www.paclii.org/vu/legis/num_act/toc-K.html.
  • 47
    • 40449086665 scopus 로고    scopus 로고
    • Dose translation from animal to human studies revisited
    • Reagan-Shaw S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008, 22:659-661.
    • (2008) FASEB J , vol.22 , pp. 659-661
    • Reagan-Shaw, S.1    Nihal, M.2    Ahmad, N.3
  • 48
    • 70449493312 scopus 로고    scopus 로고
    • Rapid identification of bacterial isolates from aqueous kava (Piper methysticum) extracts by polymerase chain reaction and DNA sequencing
    • Kandukuru P., Huang A.S., Dong J., Bittenbender H.C., Li Y. Rapid identification of bacterial isolates from aqueous kava (Piper methysticum) extracts by polymerase chain reaction and DNA sequencing. Appl Microbiol 2009, 49:764-768.
    • (2009) Appl Microbiol , vol.49 , pp. 764-768
    • Kandukuru, P.1    Huang, A.S.2    Dong, J.3    Bittenbender, H.C.4    Li, Y.5
  • 49
    • 33750687298 scopus 로고    scopus 로고
    • Determination of aflatoxins and ochratoxin A in ginseng and other botanical roots by immunoaffinity column cleanup and liquid chromatography with fluorescence detection
    • Trucksess M., Weaver C., Oles C., D'Ovidio K., Rader J. Determination of aflatoxins and ochratoxin A in ginseng and other botanical roots by immunoaffinity column cleanup and liquid chromatography with fluorescence detection. J AOAC Int 2006, 89:624-630.
    • (2006) J AOAC Int , vol.89 , pp. 624-630
    • Trucksess, M.1    Weaver, C.2    Oles, C.3    D'Ovidio, K.4    Rader, J.5
  • 50
    • 77949924657 scopus 로고    scopus 로고
    • Determination of aflatoxins in botanical roots by a modification of AOAC Official Method 991.31: single-laboratory validation
    • Weaver C.M., Trucksess M.W. Determination of aflatoxins in botanical roots by a modification of AOAC Official Method 991.31: single-laboratory validation. J AOAC Int 2010, 93:184-189.
    • (2010) J AOAC Int , vol.93 , pp. 184-189
    • Weaver, C.M.1    Trucksess, M.W.2
  • 51
    • 0016709916 scopus 로고
    • Hepatitis due to aflatoxicosis. An outbreak in Western India
    • Krishnamachari K.A., Bhat R.V., Nagarajan V., Tilak T.B. Hepatitis due to aflatoxicosis. An outbreak in Western India. Lancet 1975, 7915:1061-1063.
    • (1975) Lancet , vol.7915 , pp. 1061-1063
    • Krishnamachari, K.A.1    Bhat, R.V.2    Nagarajan, V.3    Tilak, T.B.4
  • 52
    • 0018194503 scopus 로고
    • Epidemic of toxic hepatitis in India of possible mycotoxic origin
    • Tandon H.D., Tandon B.N., Ramalingaswami V. Epidemic of toxic hepatitis in India of possible mycotoxic origin. Arch Pathol Lab Med 1978, 102:372-376.
    • (1978) Arch Pathol Lab Med , vol.102 , pp. 372-376
    • Tandon, H.D.1    Tandon, B.N.2    Ramalingaswami, V.3
  • 53
    • 0020050010 scopus 로고
    • Outbreak of acute hepatitis caused by aflatoxin poisoning in Kenya
    • Ngindu A., Johnson B.K., Ngira J.A., et al. Outbreak of acute hepatitis caused by aflatoxin poisoning in Kenya. Lancet 1982, 319:1346-1348.
    • (1982) Lancet , vol.319 , pp. 1346-1348
    • Ngindu, A.1    Johnson, B.K.2    Ngira, J.A.3
  • 54
    • 0001013981 scopus 로고
    • The origin and distribution of kava (Piper methysticum Forst. F. Piperaceae): a phytochemical approach
    • Lebot V., Lévesque J. The origin and distribution of kava (Piper methysticum Forst. F. Piperaceae): a phytochemical approach. Allertonia 1989, 5:223-281.
    • (1989) Allertonia , vol.5 , pp. 223-281
    • Lebot, V.1    Lévesque, J.2
  • 55
    • 0030236850 scopus 로고    scopus 로고
    • Genetic control of kavalactone chemotypes in Piper methysticum cultivars
    • Lebot V., Lévesque J. Genetic control of kavalactone chemotypes in Piper methysticum cultivars. Phytochemistry 1996, 43:397-403.
    • (1996) Phytochemistry , vol.43 , pp. 397-403
    • Lebot, V.1    Lévesque, J.2
  • 57
    • 0033385371 scopus 로고    scopus 로고
    • Morphological, phytochemical and genetic variation in Hawaiian cultivars of 'Awa (Kava, Piper methysticum, Piperaceae)
    • Lebot V., Johnston E., Zheng Q.Y., McKern D., McKenna D. Morphological, phytochemical and genetic variation in Hawaiian cultivars of 'Awa (Kava, Piper methysticum, Piperaceae). Econ Bot 1999, 53:407-418.
    • (1999) Econ Bot , vol.53 , pp. 407-418
    • Lebot, V.1    Johnston, E.2    Zheng, Q.Y.3    McKern, D.4    McKenna, D.5
  • 58
    • 47849099259 scopus 로고    scopus 로고
    • Quantification of kavalactones and determination of kava (Piper methysticum) chemotypes using near-infrared reflectance spectroscopy for quality control in Vanuatu
    • Lasme P., Davrieux F., Montet D., Lebot V. Quantification of kavalactones and determination of kava (Piper methysticum) chemotypes using near-infrared reflectance spectroscopy for quality control in Vanuatu. J Agric Food Chem 2008, 56:4976-4981.
    • (2008) J Agric Food Chem , vol.56 , pp. 4976-4981
    • Lasme, P.1    Davrieux, F.2    Montet, D.3    Lebot, V.4
  • 59
    • 70350123076 scopus 로고    scopus 로고
    • Kava and St. John's wort: current evidence for use in mood and anxiety disorders
    • Sarris J., Kavanagh D.J. Kava and St. John's wort: current evidence for use in mood and anxiety disorders. J Altern Complement Med 2009, 15:827-836.
    • (2009) J Altern Complement Med , vol.15 , pp. 827-836
    • Sarris, J.1    Kavanagh, D.J.2
  • 60
    • 67651005824 scopus 로고    scopus 로고
    • The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum
    • Sarris J., Kavanagh D.J., Byrne G., Bone K.M., Adams J., Deed G. The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum. Psychopharmacology 2009, 205:399-407.
    • (2009) Psychopharmacology , vol.205 , pp. 399-407
    • Sarris, J.1    Kavanagh, D.J.2    Byrne, G.3    Bone, K.M.4    Adams, J.5    Deed, G.6
  • 61
    • 0036046724 scopus 로고    scopus 로고
    • Kava extract for treating anxiety (Cochrane Review)
    • Wiley Interscience. doi:10.1002/14651858.
    • Pittler MH, Ernst E. Kava extract for treating anxiety (Cochrane Review). Cochrane Database Syst Rev 2003;(1):CD003383. Wiley Interscience. doi:10.1002/14651858.
    • (2003) Cochrane Database Syst Rev , Issue.1
    • Pittler, M.H.1    Ernst, E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.